oncology

Radiopharmaceuticals for cancer: Making radiation precise
BioPharma Dive
Tue, 08/15/23 - 11:50 am
radiopharmaceuticals
cancer
oncology
Rayze Bio
ITM
Aktis Oncology
Abdera Therapeutics
Convergent Therapeutics
Precirix
Alpha-9 Theranostics
Mariana Oncology
Ariceum Therapeutics
Ratio Therapeutics
Radionetics Oncology
Artbio
Gilead inks $66M+ deal with Tentarix in oncology, inflammatory diseases
Fierce Biotech
Tue, 08/15/23 - 11:41 am
Tentarix Biotherapeutics
Gilead Sciences
oncology
inflammatory disease
US pharmacists say drug shortages are affecting cancer care
Pharmaphorum
Thu, 08/10/23 - 10:09 pm
cancer
oncology
drug shortages
Daiichi Sankyo will remain 'dominant' in ADC market for oncology treatments
Biopharma Reporter
Mon, 08/7/23 - 10:14 am
Daiichi Sankyo
antibody drug conjugate
oncology
Seagen
Roche
Amgen Clinches Clinical Wins in SCLC and Colorectal Cancer
BioSpace
Fri, 08/4/23 - 12:30 pm
Amgen
oncology
colorectal cancer
small cell lung cancer
tarlatamab
Lumakras
Reed Jobs, son of Steve Jobs, takes the wraps off a $200 million venture fund that will back new cancer treatments
TechCrunch
Wed, 08/2/23 - 10:13 am
venture capital
Emerson Collective
oncology
Steve Jobs
Reed Jobs
Alkermes, nearing oncology split, posts big Q2 sales gain after winning J&J arbitration case
Fierce Pharma
Wed, 07/26/23 - 06:37 pm
JNJ
Alkermes
oncology
earnings
In fast-growing KRAS field, this oncology veteran is chasing the toughest cancer targets
Pharma Voice
Tue, 07/25/23 - 10:07 am
Affini-T Therapeutics
oncology
KRAS inhibitors
Gilead drug acquired in $5B buyout fails key blood cancer trial
BioPharma Dive
Mon, 07/24/23 - 11:47 am
Gilead Sciences
M&A
oncology
clinical trials
magrolimab
MDS
Forty Seven
Keytruda Keeps Racking Up Approvals and Clinical Wins in ’23
BioSpace
Thu, 07/6/23 - 11:30 am
Merck
Keytruda
oncology
cancer
Intensity Therapeutics Prices Upsized 3.9M Share IPO at $5/sh
Investing.com
Fri, 06/30/23 - 11:47 am
Intensity Therapeutics
oncology
cancer
IPOs
Lilly to Buy European ADC Player Emergence Therapeutics
BioSpace
Fri, 06/30/23 - 10:20 am
Eli Lilly
M&A
Emergence Therapeutics
antibody-drug conjugate
oncology
Artificial intelligence advances cancer diagnostics in the next decade
Clinical Trials Arena
Thu, 06/22/23 - 10:08 am
diagnostics
Medtech
artificial intelligence
cancer
oncology
Mindpeak
Proscia
Bayer needs 'midsize acquisition' to reach $10B oncology sales goal, exec says
Fierce Pharma
Mon, 06/12/23 - 11:22 pm
Bayer
oncology
M&A
BIO: Jazz is auditioning new bandmates in an M&A market ripe with talent
Fierce Biotech
Tue, 06/6/23 - 11:16 am
Jazz Pharmaceuticals
Bruce Cozadd
M&A
BIO 2023
neurology
oncology
Acepodia Secures $100 Million Series D Financing to Advance
BioSpace
Tue, 06/6/23 - 10:02 am
Acepodia
funding
oncology
gamma delta T cells
ACE1831
Pricing law jeopardizes post-approval R&D process for cancer pills: analysis
Medical Marketing and Media
Mon, 06/5/23 - 10:04 pm
Inflation Reduction Act
R&D
drug pricing
oncology
Bayer to acquire exclusive license from Cedilla Therapeutics on selective inhibitors in pre-clinical precision oncology
BioSpace
Thu, 06/1/23 - 06:43 pm
Bayer
Cedilla Therapeutics
CyclinE1/CDK2 inhibitors
oncology
precision oncology
Rain Oncology to cut 65% of staff after milademetan Phase 3 trial failure
Medical Marketing and Media
Wed, 05/31/23 - 11:00 am
Rain Oncology
layoffs
clinical trials
milademetan
oncology
solid tumors
Takeda puts $510M on the line to expand KSQ cancer collaboration
Fierce Biotech
Wed, 05/17/23 - 10:09 am
Takeda
KSQ Therapeutics
cancer
oncology

Pages